How to Identify Potential Candidates for HIV Pre-Exposure Prophylaxis: An AI Algorithm Reusing Real-World Hospital Data

被引:5
|
作者
Duthe, Jean-Charles [1 ,2 ]
Bouzille, Guillaume [1 ]
Sylvestre, Emmanuelle [1 ,3 ]
Chazard, Emmanuel [4 ]
Arvieux, Cedric [2 ,5 ]
Cuggia, Marc [1 ]
机构
[1] Univ Rennes, CHU Rennes, Inserm, LTSI UMR 1099, F-35000 Rennes, France
[2] COREVIH Bretagne, Rennes, France
[3] CHU Martinique, Ctr Donnees Clin, F-97200 Fort De France, Martinique, France
[4] Univ Lille, Publ Hlth Dept, CHU Lille, ULR 2964,METRICS,CERIM, F-59000 Lille, France
[5] CHU Rennes, Infect Dis & Emergency Unit, F-35000 Rennes, France
关键词
Pre-exposure prophylaxis (PrEP); HIV prevention; clinical informatics; predictive analytics; sexual health; risk reduction practices; machine learning; RISK;
D O I
10.3233/SHTI210265
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
HIV Pre-Exposure Prophylaxis (PrEP) is effective in Men who have Sex with Men (MSM), and is reimbursed by the social security in France. Yet, PrEP is underused due to the difficulty to identify people at risk of HIV infection outside the "sexual health" care path. We developed and validated an automated algorithm that re-uses Electronic Health Record (EHR) data available in eHOP, the Clinical Data Warehouse of Rennes University Hospital (France). Using machine learning methods, we developed five models to predict incident HIV infections with 162 variables that might be exploited to predict HIV risk using EHR data. We divided patients aged 18 or more having at least one hospital admission between 2013 and 2019 in two groups: cases (patients with known HIV infection in the study period) and controls (patients without known HIV infection and no PrEP in the study period, but with at least one HIV risk factor). Among the 624,708 admissions, we selected 156 cases (incident HIV infection) and 761 controls. The best performing model for identifying incident HIV infections was the combined model (LASSO, Random Forest, and Generalized Linear Model): AUC = 0.88 (95% CI: 0.8143-0.9619), specificity = 0.887, and sensitivity = 0.733 using the test dataset. The algorithm seems to efficiently identify patients at risk of HIV infection.
引用
收藏
页码:714 / 718
页数:5
相关论文
共 50 条
  • [31] The potential impact of PrEP (pre-exposure prophylaxis) in a single HIV centre
    Cavilla, S.
    [J]. HIV MEDICINE, 2016, 17 : 31 - 31
  • [32] Pre-exposure prophylaxis for HIV infection may be effective in older candidates, but proceed with caution
    Only, Group Author
    [J]. DRUGS & THERAPY PERSPECTIVES, 2019, 35 (01) : 21 - 23
  • [34] Self-report and medication possession ratio are accurate measures of HIV pre-exposure prophylaxis use in a real-world clinical setting
    Patel, R.
    Harrison, L.
    Liu, A.
    Chan, P.
    Presti, R.
    Anderson, P.
    Mayer, K.
    Liu, J.
    Powderly, W.
    Amico, K. R.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20 : 58 - 58
  • [35] Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study
    Jourdain, Hugo
    de Gage, Sophie Billioti
    Desplas, David
    Dray-Spira, Rosemary
    [J]. LANCET PUBLIC HEALTH, 2022, 7 (06): : E529 - E536
  • [36] Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP)
    Hongyi Wang
    Yonghui Zhang
    Zhu Mei
    Yueru Jia
    Sequoia I. Leuba
    Jing Zhang
    Zhenxing Chu
    Haibo Ding
    Yongjun Jiang
    Wenqing Geng
    Hong Shang
    Junjie Xu
    [J]. BMC Infectious Diseases, 19
  • [37] Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP)
    Wang, Hongyi
    Zhang, Yonghui
    Mei, Zhu
    Jia, Yueru
    Leuba, Sequoia I.
    Zhang, Jing
    Chu, Zhenxing
    Ding, Haibo
    Jiang, Yongjun
    Geng, Wenqing
    Shang, Hong
    Xu, Junjie
    [J]. BMC INFECTIOUS DISEASES, 2019, 19 (01)
  • [38] Pre-exposure of Prophylaxis to Prevent HIV Infection - current Data and Recommendations
    Kuemmerle, T.
    Foewtkenheuer, G.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (44) : 2285 - 2288
  • [39] Using HIV Risk Prediction Tools to Identify Candidates for Pre-Exposure Prophylaxis: Perspectives from Patients and Primary Care Providers
    Gilkey, Melissa B.
    Marcus, Julia L.
    Garrell, Jacob M.
    Powell, Victoria E.
    Maloney, Kevin M.
    Krakower, Douglas S.
    [J]. AIDS PATIENT CARE AND STDS, 2019, 33 (08) : 372 - 378
  • [40] Real-World Efficacy of COVID-19 Pre-Exposure Prophylaxis with Tixagevimab/Cilgavimab in People with Multiple Sclerosis
    Elias, Luke B.
    Jaber, Aliya
    Manzano, Margarita
    Leekoff, Mark
    Sylvester, Andrew
    Tremblay, Matthew A.
    [J]. VACCINES, 2023, 11 (12)